Replies to post #427 on Biogen Inc (BIIB)

[Cbdpotential]

Great question, in my opinion, Anavex is either holding its cards tight in an attempt to grow their pipeline into a major BP without having to give up pennies on the dollars, or current BP’s are simply waiting (possibly in fear) for the data from Anavex’s current trials. Or of course, Anavex doesn’t have “the goods”.

Biogen has/is still testing anavex’s lead drug candidate Anavex 2-73. It’s possible Biogen is, too, holding some of the same cards behind closed doors.

One thing is for sure, 2019 seems to have a very different feel in bio land.

It’s time to embrace new, and many, perspectives.

All jmho of course.

[Whatsupp]

Beware Anavex is continuing its retail investor scam. Starting another AMT deal and about to dilute even more with new issue of Preferred stock.

Same game as documented here.

https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6


"After studying the history of Anavex from its inception to today, it appears in my opinion, that the only business Anavex Life Sciences has really ever been in, has been the business of filing, issuing and selling new shares of little to no value to the unsuspecting public, on that count it seems to have been an extremely successful venture"